Palavras-chave
doença renal
prognóstico
biomarcador
Como Citar
Resumo
Lipocalina associada à gelatinase neutrofílica (NGAL) é uma molécula proteica predominantemente expressa na parte distal do néfron após a ocorrência de lesão renal. Diferentemente da creatinina sérica e da taxa de filtração glomerular, que são marcadores de função renal, os níveis aumentados de NGAL, tanto no soro quanto na urina, estão intimamente ligados a lesões estruturais do néfron. Os estudos clínicos indicam que poucas horas após a ocorrência da lesão renal aguda os níveis séricos e urinários de NGAL já se apresentam significativamente elevados, enquanto os níveis séricos de creatinina e a sua depuração renal apenas sofrem alterações significativas entre 24-48h após a lesão. Assim, a utilização de marcadores de função renal, usualmente avaliados na prática clínica, pode apresentar algumas limitações além de dificultar a aplicação de medidas precoces que visam a proteção renal. Esta revisão da literatura tem por objetivo analisar os aspectos biológicos e as aplicações da mensuração de NGAL em algumas condições clínicas, incluindo injúria renal, nefropatias e isquemia renal.
Referências
1. MA. The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clin Cancer Res. 2005;11(15):5390-5. [DOI: 10.1158/1078-0432.CCR-04-2391].
2. Kjeldsen L, Bainton DF, Sengelov H, Borregaard N. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood. 1994;83(3):799-807.
3. Nielsen BS, Borregaard N, Bundgaard JR, Timshel S, Sehested M, Kjeldsen L. Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut. 1996;38(3):414-20.
4. Hvidberg V, Jacobsen C, Strong RK, Cowland JB, Moestrup SK, Borregaard N. The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett. 2005;579(3):773-7. [DOI: 10.1016/j.febslet.2004.12.031].
5. Bolignano D, Donato V, Coppolino G, Campo S, Buemi A, Lacquaniti A, et al. Neutrophil Gelatinase–Associated Lipocalin (NGAL) as a Marker of Kidney Damage. Am J Kidney Dis. 2008;52(3):595-605. [DOI: 10.1053/j.ajkd.2008.01.020]
6. Yang J, Goetz D, Li JY, Wang W, Mori K, Setlik D, et al. An iron delivery pathway mediated by a lipocalin. Mol Cell. 2002;10(5):1045-56. [DOI: 10.1016/S1097-2765(02)00710-4].
7. Rubinstein T, Pitashny M, Putterman C. The novel role of neutrophil gelatinase-B associated lipocalin (NGAL)/Lipocalin-2 as a biomarker for lupus nephritis. Autoimmun Rev. 2008;7(3):229-34. [DOI: 10.1016/j.autrev.2007.11.013].
8. Haase M, Devarajan P, Haase-Fielitz A, Bellomo R, Cruz DN, Wagener G, et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: A multicenter pooled analysis of prospective studies. J Am Coll Cardiol. 2011;57(17):1752-61. [DOI: 10.1016/j.jacc.2010.11.051].
9. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, 9. Ma Q, Kelly C, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365(9466):1231–8. [DOI: 10.1016/S0140-6736(05)74811-x].
10. Fjaertoft G, Foucard T, Xu S, Venge P. Human neutrophil lipocalin (HNL) as a diagnostic tool in children with acute infections: A study of the kinetics. Acta Paediatr. 2005;94(6):661-6. [DOI:10.1080/08035250510031610].
11. Singer E, Markó L, Paragas N, Barasch J, Dragun D, Müller DN, et al. Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications. Acta Physiol (Oxf ). 2013;207(4):663-72. [DOI: 10.1111/apha.12054].
12. Glassock RJ. Prevention of microalbuminuria in type 2 diabetes: millimeters or milligrams. J Am Soc Nephrol. 2006;17(12):3276-8. [DOI: 10.1681/ASN.2006101131].
13. Devarajan, P. Review: Neutrophil gelatinase-associated lipocalin: a troponin-like biomarker for human acute kidney injury. Nephrology (Carlton). 2010;15(4):419-28. [DOI: 10.1111/j.1440-1797.2010.01317.x].
14. Matheson A, Willcox MD, Flanagan J, Walsh BJ. Urinary biomarkers involved in type 2 diabetes: a review. Diabetes Metab Res Rev. 2010;26(3):150-71. [DOI: 10.1002/dmrr.1068].
15. Flower DR. The lipocalin protein family: Structure and function. Biochem J. 1996;318(1):1-14. [DOI: 10.1042/bj3180001].
16. Goetz DH, Willie ST, Armen RS, Bratt T, Borregaard N, Strong RK. Ligand preference inferred from the structure of neutrophil gelatinase associated lipocalin. Biochemistry. 2000;39(8):1935-41. [DOI:10.1021/bi992215v].
17. Tomonaga Y, Szucs T, Ambühl P, Nock S, Risch M, Risch L. Insights on urinary NGAL obtained in a primary care setting. Clin Chim Acta. 2012;413(7-8):733–9. [DOI: 10.1016/j.cca.2012.01.001].
18. Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J, et al. Endocytic delivery of lipocalin-siderophoreiron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest. 2005;115(3):610–21. [DOI: 10.1172/JCI200523056].
19. Mahdavi-Mazdeh M, Abdollahi A, Nozary HB, Sobhani Z. Comparison of serum and urine neutrophil gelatinase-associated lipocalin (NGAL) with serum creatinine in prediction of kidney suitability for transplantation. Nephrourol Mon. 2013;5(1):679-82. [DOI: 10.5812/numonthly.5002].
20. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature. 2004;432(7019):917-21. [DOI:10.1038/nature03104].
21. Lassnigg A, Schmid ER, Hiesmayr M, Falk C, Druml W, Bauer P, et al. Impact of minimal increases in serum creatinine on outcome in patients after cardiothoracic surgery: do we have to revise current definitions of acute renal failure? Crit Care Med. 2008;36(4):1129–37. [DOI: 10.1097/CCM.0b013e318169181a].
22. Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003;14(10):2534–43. [DOI:10.1097/01.ASN.0000088027.54400.C6].
23. Bennett M, Dent CL, Ma Q, Dastrala S, Grenier F, Workman R, et al. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol. 2008;3(3):665-673. [DOI: 10.2215/CJN.04010907].Haase M, Bellomo R, Devarajan P, Schlattmann P,
24. Haase-Fielitz A, NGAL Meta-analysis Investigator Group. Accuracy of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Diagnosis and Prognosis in Acute Kidney Injury: A Systematic Review and Meta-analysis. Am J Kidney Dis. 2009;54(6):1012-24. [DOI: 10.1053/j.ajkd.2009.07.020].
25. Kim H, Hur M, Cruz DN, Moon HW, Yun YM. Plasma neutrophil gelatinase-associated lipocalin as a biomarker for acute kidney injury in critically ill patients with suspected sepsis. Clin Biochem. 2013;46(15):1414-8. [DOI: 10.1016/j.clinbiochem.2013.05.069].
26. Payen D, Lukaszewicz AC, Legrand M, Gayat E, Faivre V, Megarbane B, et al. A multicentre study of acute kidney injury in severe sepsis and septic shock: association with inflammatory phenotype and HLA genotype. PLoS One. 2012;7(6):e35838. [DOI: 10.1371/journal.pone.0035838].
27. Doi K, Urata M, Katagiri D, Inamori M, Murata S, Hisagi M, et al. Plasma neutrophil gelatinase-associated lipocalin in acute kidney injury superimposed on chronic kidney disease after cardiac surgery: a multicenter prospective study. Crit Care. 2013;17(6):R270. [DOI: 10.1186/cc13104].
28. Moon SJ, Park HB, Yoon SY, Lee SC. Urinary biomarkers for early detection of recovery in patients with acute kidney injury. J Korean Med Sci. 2013;28(8):1181-6. [DOI: 10.3346/jkms.2013.28.8.1181. Epub 2013 Jul 31].
29. Rostami Z, Nikpoor M, Einollahi B. Urinary neutrophil gelatinase associated lipocalin (NGAL) for early diagnosis of acute kidney injury in renal transplant recipients. Nephrourol Mon. 2013;5(2):745-52. [DOI: 10.5812/numonthly.9385].
30. Ibels LS, Gyory AZ, Caterson RJ, Pollock CA, Mahony JF, Waugh DA, et al. Primary IgA nephropathy: natural history and factors of importance in the progression of renal impairment. Kidney Int Suppl. 1997;61:S67–S70.
31. Ding H, He Y, Li K, Yang J, Li X, Lu R, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin Immunol. 2007;123(2):227-34. [DOI: 10.1016/j.clim.2007.01.010].
32. Peters HP, Waanders F, Meijer E, van den Brand J, Steenbergen EJ, van Goor H, et al. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy. Nephrol Dial Transplant. 2011;26(11):1-8. [DOI: 10.1093/ndt/gfr135].
33. Hinze CH, Suzuki M, Klein-Gitelman M, Passo MH, Olson J, Singer NG, et al. Neutrophil gelatinase–associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity. Arthritis Rheum. 2009;60(9):2772–81. [DOI: 10.1002/art.24751].
34. Yang CC, Hsieh SC, Li KJ, Wu CH, Lu MC, Tsai CY, et al. Urinary neutrophil gelatinase-associated lipocalin is a potential biomarker for renal damage in patients with systemic lupus erythematosus. J Biomed Biotechnol. 2012;2012:759313.[DOI: 10.1155/2012/759313].
35. Brunner HI, Bennett MR, Mina R, Suzuki M, Petri M, Kiani AN, et al. Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis. Arthritis Rheum. 2012;64(8):2687-97. [DOI: 10.1002/art.34426].
36. Yilmaz A, Sevketoglu E, Gedikbasi A, Karyagar S, Kiyak A, Mulazimoglu M, et al. Early prediction of urinary tract infection with urinary neutrophil gelatinase associated lipocalin. Pediatr Nephrol. 2009;24(12):2387–92. [DOI: 10.1007/s00467-009-1279-6].
37. Bagshaw SM, Bellomo R, Devarajan P, Johnson C, Karvellas CJ, Kutsiogiannis DJ, et. al. Review article: acute kidney injury in critical illness. Can J Anaesth. 2010;57(11):985–98. [DOI: 10.1007/s12630-010-9375-4].
38. Fanning N, Galvin S, Parke R, Gilroy J, Bellomo R, McGuinness S. A prospective study of the timing and accuracy of neutrophil gelatinase-associated lipocalin levels in predicting acute kidney injury in high-risk cardiac surgery patients. J Cardiothorac Vasc Anesth. 2016;30(1):76-81. [DOI: 10.1053/j.jvca.2015.07.034]. [Epub 2015 jul30].
39. Wyckoff T, Augoustides JG. Advances in acute kidney injury associated with cardiac surgery: the unfolding revolution in early detection. J Cardiothorac Vasc Anesth. 2012;26(2):340-5. [DOI: 10.1053/j.jvca.2012.01.001].
40. Wagener G, Jan M, Kim M, Mori K, Barasch JM, Sladen RN, et al. Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology. 2006;105(3):485–91.
41. Parikh CR, Devarajan P, Zappitelli M, Sint K, Thiessen-Philbrook H, Li S, et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery. J Am Soc Nephrol. 2011;22(9):1737-47. [DOI: 10.1681/ASN.2010111163].
42. Parving HH, Mauer M, Ritz E. In: Brenner & Rector’s The Kidney. 8ª ed. Boston (WB):Saunders; 2008.
43. Birn H, Christensen EI. Renal albumin absorption in physiology and pathology. Kidney Int. 2006;69(3):440–9. [DOI: 10.1038/sj.ki.5000141].
44. Brocco E, Fioretto P, Mauer M, Saller A, Carraro A, Frigato F, et al. Renal structure and function in non-insulin dependent diabetic patients with microalbuminuria. Kidney Int. 1997;63:S40–4.
45. Nielsen SE, Schjoedt KJ, Astrup AS, Tarnow L, Lajer M, Hansen PR, et al. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril. Diabet Med. 2010;27(10):1144-50. [DOI: 10.1111/j.1464-5491.2010.03083.x].
46. Bolignano D, Lacquaniti A, Coppolino G, Donato V, Fazio MR, Nicocia G, et al. Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. Kidney Blood Press Res. 2009;32(2):91–8. [DOI: 10.1159/000209379].
47. Carvalho JAM, Tatsch E, Hausen BS, Bollick YS, Moretto MB, Duarte T, et al. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes. Clin Biochem. 2016;49(3):232-6. [DOI: 10.1016/j.clinbiochem.2015.10.016]. [Epud 2015 Oct 27].
48. Grenier FC, Ali S, Syed H, Workman R, Martens F, Liao M, et al. Evaluation of the ARCHITECT urine NGAL assay: assay performance, specimen handling requirements and biological variability. Clin Biochem. 2010;43(6):615–20.[DOI:10.1016/j.clinbiochem.2009.12.008].van de Vrie M, Deegens JK,
49. van der Vlag J, Hilbrands LB. Effect of long-term storage of urine samples on measurement of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL). Am J Kidney Dis. 2014;63(4):573-6. [DOI:10.1053/j.ajkd.2013.10.010].
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Copyright (c) 2016 Matheus Wagner Lago, Rafael Noal Moresco, Guilherme Vargas Bochi